BCG Tuberculosis Vaccine — Calmette and Guérin (1921)

Developed at the Pasteur Institute in Lille, France from an attenuated strain of Mycobacterium bovis, BCG remains the most widely used vaccine in history with over 4 billion doses administered. Despite variable efficacy against adult pulmonary TB, it prevents severe childhood tuberculosis and remains essential in endemic regions.